CME Group (CME) has quietly tidied up a niche corner of its capital structure. The firm eliminated its unused Series G non voting convertible preferred stock, following a May 2026 board decision.
The tidy up comes while CME Group’s share price has moved in a fairly mixed pattern, with a 7 day share price return of 2.64% sitting against a 30 day share price return that fell 3.95%. However, a 90 day share price return of 11.15% and a 1 year total shareholder return of 6.47% point to momentum that has been building over a longer stretch as investors weigh product launches in areas like AI compute and new agricultural contracts against decisions such as pausing the 24/7 crude contract and recent tweaks to the capital structure.
Spot opportunities beyond CME Group by scanning a curated set of 91 AI infrastructure stocks that could also benefit from rising interest in AI compute and related derivatives markets.CME Group now appears to be a more focused derivatives powerhouse after scrapping an unused preferred class. The key question is straightforward: does a premium business at around $270 a share still offer fair value today?
Most Popular Narrative: 4.7% Undervalued
On the most followed view, CME Group screens modestly cheap, with a fair value of $283.60 sitting above the last close at $270.18. That gap is small, so the story leans heavily on how new products and clearing projects could justify the difference.
New product introductions, such as single stock futures, compute futures on NVIDIA H100 rental costs, E mini Equity Factor futures, wind power contracts, leveraged loan index futures and a planned entry into European dairy, together with ongoing technology driven efficiencies from cloud migration and tokenization projects, give CME Group more ways to grow transaction and market data revenue while supporting high net margins.
See why 52 investors see CME Group as 5% undervalued.
Result: Fair Value of $283.60 (UNDERVALUED)
Still, the CME Group story can break if competitors chip away at key rate or energy contracts, or if crypto and perpetual futures evolve in less friendly ways.
Find out about the key risks to this CME Group narrative.
Another View: What CME Group’s P/E Is Really Saying
There is a catch. CME Group screens as 4.7% undervalued on fair value, yet the stock trades on a 22.8x P/E versus a fair ratio of 14.4x. It is still below both the US Capital Markets average of 39.7x and a 24.8x peer group.
That mix of a premium to the fair ratio, but a discount to sector and peers, leaves a simple question: is the current multiple paying up for quality, or paying ahead of itself for future growth that might not arrive as quickly as expected?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Sentiment on CME Group is mixed, with real risks on the table alongside clear positives that bulls keep pointing to. Act while the facts are fresh in your mind and weigh both the concerns and potential upsides using the 2 key rewards and 2 important warning signs
Looking for more CME Group style investment ideas?
If you want to keep sharpening your edge beyond CME Group, use the Simply Wall St Screener to surface fresh ideas before the crowd moves in.
- Target quality at a discount by scanning our 27 high quality undervalued stocks and see which companies currently trade below their assessed worth.
- Lift your income potential by reviewing a hand picked set of 8 dividend fortresses that focus on stronger yield profiles.
- Dial down portfolio stress by filtering for 31 resilient stocks with low risk scores that score well on resilience and financial stability metrics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com